Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
1.140
0.00 (0.00%)
Jun 18, 2025, 4:00 PM - Market closed
Pyxis Oncology Market Cap
Pyxis Oncology has a market cap or net worth of $70.62 million as of June 20, 2025. Its market cap has decreased by -68.11% in one year.
Market Cap
70.62M
Enterprise Value
-14.97M
1-Year Change
-68.11%
Ranking
Category
Stock Price
$1.14
Market Cap Chart
Since the IPO on October 1, 2021, Pyxis Oncology's market cap has decreased from $523.75M to $70.62M, a decrease of -86.52%. That is a compound annual growth rate of -41.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 70.62M | -23.87% |
| Dec 31, 2024 | 92.77M | 16.32% |
| Dec 29, 2023 | 79.75M | 70.77% |
| Dec 30, 2022 | 46.70M | -86.78% |
| Dec 31, 2021 | 353.33M | -32.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 704.75B |
| Johnson & Johnson | 362.67B |
| Novo Nordisk | 331.06B |
| AbbVie | 327.65B |
| UnitedHealth Group | 278.67B |
| Abbott Laboratories | 230.37B |
| Novartis AG | 227.75B |
| AstraZeneca | 220.36B |